Ginni Filaments Publishes FY26 Audited Results; Re-appoints AW & Co. as Internal Auditor

6 min read     Updated on 07 May 2026, 04:13 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Ginni Filaments Limited reported strong FY26 audited results with revenue from operations of ₹36,870.05 lacs and net profit of ₹3,703.77 lacs, subsequently publishing the results in Business Standard and Dainik Jagran on May 07, 2026, per SEBI Regulation 30 & 47(4). The Board also re-appointed M/s A W & Co. as Internal Auditor for FY 2026-27, while the Garments Division was closed and classified as discontinued operations with an exceptional loss of ₹545.79 lacs recognised during the year.

powered bylight_fuzz_icon
39531500

*this image is generated using AI for illustrative purposes only.

Ginni Filaments Limited reported its audited financial results for the quarter and year ended March 31, 2026, as approved by its Board of Directors at a meeting held on May 5, 2026. The results were prepared in accordance with the Companies (Indian Accounting Standards) Rules, 2015, as amended (Ind AS), and were audited by M/s Doogar & Associates, Chartered Accountants (FRN: 000561N), who issued an unmodified audit opinion. In compliance with Regulation 30 & 47(4) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company subsequently published the audited financial results in Business Standard (English edition) and Dainik Jagran (Hindi edition), both dated May 07, 2026. The advertisement also includes a Quick Response code and a web-link to access the complete financial results, which are also hosted on the company's website at www.ginnifilaments.com . At the same Board meeting, the Board approved the re-appointment of M/s A W & Co., Chartered Accountants (FRN-002338N), as the Internal Auditor of the company for Financial Year 2026-27.

Financial Performance Overview

The company delivered a strong performance for the full year ended March 31, 2026. Revenue from operations rose to ₹36,870.05 lacs from ₹29,989.84 lacs in the previous year. Total income, including other income of ₹183.34 lacs, stood at ₹37,053.39 lacs compared to ₹30,551.24 lacs in the prior year. Profit before exceptional items and tax from continuing operations reached ₹5,478.57 lacs, significantly higher than ₹1,728.01 lacs in the previous year. After accounting for an exceptional loss of ₹545.79 lacs related to the closure of the Garments Undertaking, profit before tax from continuing operations was ₹4,932.78 lacs.

The following table summarises the key financial metrics for the year and the most recent quarter:

Metric: Q4 FY26 (31-Mar-26) Q3 FY26 (31-Dec-25) Q4 FY25 (31-Mar-25) FY26 FY25
Revenue from Operations (₹ lacs): 9,010.36 8,999.95 36,870.05 29,989.84
Total Income (₹ lacs): 9,043.96 8,267.22 9,287.85 37,053.39 30,551.24
Total Expenses (₹ lacs): 8,033.32 7,958.06 31,574.82 28,823.23
Profit Before Tax – Continuing Operations (₹ lacs): 1,010.64 1,198.68 1,329.79 4,932.78 1,728.01
Net Profit from Continuing Operations (₹ lacs): 716.09 902.52 996.21 4,096.58 1,747.31
Net Profit for the Period (₹ lacs): 712.82 904.35 478.77 3,703.77 419.53
Total Comprehensive Income (₹ lacs): 615.13 913.50 455.70 3,619.81 472.69
Basic & Diluted EPS – Continuing & Discontinued (₹): 0.84 1.05 0.56 4.32 0.49
Basic & Diluted EPS – Continuing Operations (₹): 0.84 1.05 1.16 4.78 2.04

Segment-Wise Performance

The company operates across two primary segments — Textiles and Consumer Products — with the Garments division classified as discontinued operations during the year. The Consumer Products segment recorded notable revenue growth, rising to ₹20,562.04 lacs for the full year from ₹11,802.40 lacs in the prior year. The Textiles segment reported revenue of ₹23,836.98 lacs compared to ₹22,718.42 lacs previously.

Segment: FY26 Revenue (₹ lacs) FY25 Revenue (₹ lacs) FY26 EBIT (₹ lacs) FY25 EBIT (₹ lacs)
Textiles: 23,836.98 22,718.42 3,696.65 1,986.23
Consumer Products: 20,562.04 11,802.40 2,230.87 506.16
Total (before inter-segment): 44,399.02 34,520.82 5,927.52 2,492.39

Discontinued Operations – Garments Division

The Board of Directors, at its meeting held on May 7, 2025, approved the closure of the Garments Division and the subsequent disposal of related assets and liabilities. The assets of the Garments Undertaking were classified as "Assets Held for Sale" upon closure during the quarter ended June 30, 2025, and the company disposed of these assets during the year ended March 31, 2026. An exceptional loss of ₹545.79 lacs was recognised on the remeasurement of assets classified as held for sale, determined at the lower of their carrying amount and fair value less costs to sell.

The discontinued Garments division reported a loss after tax of ₹392.81 lacs for the full year ended March 31, 2026, compared to a loss of ₹1,327.78 lacs in the previous year. Revenue from the discontinued operations stood at ₹1,007.52 lacs for the year, against ₹7,388.60 lacs in the prior year.

Balance Sheet Highlights

As at March 31, 2026, the company's total assets stood at ₹32,865.14 lacs compared to ₹33,598.45 lacs as at March 31, 2025. Total equity improved to ₹23,556.40 lacs from ₹19,936.59 lacs, reflecting the strong profitability during the year. Total liabilities declined to ₹9,308.74 lacs from ₹13,661.86 lacs, driven by a reduction in current borrowings from ₹5,316.03 lacs to ₹2,511.34 lacs. Reserves (excluding Revaluation Reserve) as shown in the audited Balance Sheet stood at ₹14,991.39 lacs for FY26 compared to ₹11,371.58 lacs for FY25.

Balance Sheet Metric: March 31, 2026 (₹ lacs) March 31, 2025 (₹ lacs)
Total Assets: 32,865.14 33,598.45
Total Equity: 23,556.40 19,936.59
Paid-up Equity Share Capital: 8,565.01 8,565.01
Reserves (excl. Revaluation Reserve): 14,991.39 11,371.58
Non-Current Liabilities: 3,133.64 4,133.94
Current Liabilities: 6,175.10 9,527.92
Total Liabilities: 9,308.74 13,661.86
Cash and Cash Equivalents: 24.98 311.29

Cash Flow Performance

For the year ended March 31, 2026, net cash inflow from operating activities was ₹6,132.03 lacs, compared to ₹1,036.27 lacs in the prior year. Net cash outflow from investing activities was ₹2,601.25 lacs, while net cash outflow from financing activities was ₹3,817.09 lacs, resulting in a net decrease in cash and cash equivalents of ₹286.31 lacs. Closing cash and cash equivalents stood at ₹24.98 lacs.

Internal Auditor Re-Appointment

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board approved the re-appointment of M/s A W & Co., Chartered Accountants (FRN-002338N), as the Internal Auditor of Ginni Filaments for Financial Year 2026-27, for a period of one year. The firm comprises two partners with a combined professional experience of over 46 years and is equipped to handle statutory audit, internal audit, taxation, and financial controls, among other professional activities.

Re-appointment Details: Information
Firm Name: M/s A W & Co., Chartered Accountants
Firm Registration Number: FRN-002338N
Nature of Change: Re-appointment
Tenure: 1 year (FY 2026-27)
Approval Date: May 05, 2026
Combined Partner Experience: Over 46 years
Key Capabilities: Statutory Audit, Internal Audit, Taxation, Financial Controls, Company Law Matters

Newspaper Publication Details

In compliance with Regulation 30 & 47(4) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ginni Filaments published its audited financial results for the quarter and year ended March 31, 2026 in two newspapers on May 07, 2026. The publication covered an extract of the detailed financial results as filed with the stock exchanges under Regulation 33 of SEBI (LODR) Regulations, 2015.

Publication Details: Information
English Newspaper: Business Standard
Hindi Newspaper: Dainik Jagran
Publication Date: May 07, 2026
Regulatory Compliance: Regulation 30 & 47(4) of SEBI (LODR) Regulations, 2015
Signed By: Bharat Singh, Company Secretary (Membership No. F6459)
Company Website: www.ginnifilaments.com

Historical Stock Returns for Ginni Filaments

1 Day5 Days1 Month6 Months1 Year5 Years
-2.94%+6.30%+24.24%+4.94%+87.89%+63.69%

With the Garments Division fully wound down and its assets disposed of, how does Ginni Filaments plan to redeploy the freed-up capital to sustain the Consumer Products segment's near-doubling revenue growth beyond FY26?

Given the sharp reduction in current borrowings from ₹5,316 lacs to ₹2,511 lacs, is the company considering further deleveraging or will it pursue debt-funded capacity expansion in its high-growth Consumer Products segment?

The Consumer Products segment's EBIT surged from ₹506 lacs to ₹2,230 lacs — what competitive or pricing pressures could threaten the sustainability of these margins in FY27?

Ginni Filaments Board Approves ₹132 Crore Multi-Segment Capacity Expansion

3 min read     Updated on 06 May 2026, 04:56 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Ginni Filaments' board approved ₹132 crore in multi-segment expansions on May 5, 2026, covering a new spunlace non-woven line (₹94 crore, 10,000 MT) and solar project (₹13 crore, 3 MW) at Panoli, kitchen roll and medical product capacity (₹10 crore) at CPD Panoli, and cosmetics expansion (₹15 crore, 800 MT) at Haridwar, all financed 25% via internal accruals and 75% via term loans.

powered bylight_fuzz_icon
39559924

*this image is generated using AI for illustrative purposes only.

Ginni Filaments has received board approval for a sweeping multi-segment capacity expansion programme spanning its facilities at Panoli and Haridwar. At its board meeting held on May 5, 2026, the company's directors approved investments totalling ₹132 crore across four distinct projects — covering spunlace non-woven manufacturing, solar power, kitchen roll and medical products, and cosmetics. Each project is to be financed through a combination of internal accruals (25%) and term loans (75%), underscoring the company's structured approach to funding its growth agenda.

Spunlace Non-Woven Expansion at Panoli

The largest component of the approved programme is the addition of a new spunlace line at the Panoli facility. The board has greenlit an investment of ₹94 crore to add 10,000 MT of annual production capacity to the existing 11,000 MT, with the existing unit already operating at over 90% capacity utilisation. The rationale cited is diversification of products and potential growth in demand. The key parameters of this expansion are outlined below:

Parameter: Details
Existing Capacity (Annual): 11,000 MT
Existing Capacity Utilisation: 90%+
Proposed Capacity Addition (Annual): 10,000 MT
Timeline: March 2026 – April 2027
Investment Required: ₹94 crore
Mode of Financing: Internal accruals – 25%, Term Loan – 75%

Solar Power Project at Panoli

Alongside the non-woven expansion, the board has also approved a ₹13 crore investment to add 3 MW of solar power capacity at Panoli. The existing 5 MW solar installation is currently under installation. The new solar capacity is intended to provide cost-effective captive power for the new spunlace non-woven line, with completion targeted between May 2026 and April 2027.

Parameter: Details
Existing Solar Capacity (Annual): 5 MW
Existing Capacity Utilisation: Under installation
Proposed Capacity Addition (Annual): 3 MW
Timeline: May 2026 – April 2027
Investment Required: ₹13 crore
Mode of Financing: Internal accruals – 25%, Term Loan – 75%

CPD Panoli — Kitchen Roll and Medical Products

The board has further approved a ₹10 crore investment at the CPD Panoli unit to expand kitchen roll capacity and introduce new medical product lines. The existing kitchen roll capacity stands at 24,00,000 units annually, currently operating at 60% utilisation. The proposed addition will raise kitchen roll capacity to 50,00,000 units annually. In addition, new machinery with the capacity to convert 600 MT of spunlace non-woven annually will be installed to manufacture medical application products such as gauzes, swabs, and bandages. This expansion is slated for completion between May 2026 and December 2026.

Parameter: Details
Existing Kitchen Roll Capacity (Annual): 24,00,000 units
Existing Capacity Utilisation: 60%
Proposed Kitchen Roll Capacity Addition (Annual): 50,00,000 units
New Medical Products Conversion Capacity (Annual): 600 MT spunlace non-woven
Timeline: May 2026 – December 2026
Investment Required: ₹10 crore
Mode of Financing: Internal accruals – 25%, Term Loan – 75%

CPD Haridwar — Cosmetics Division Expansion

The fourth approved project involves a significant scale-up of the cosmetics division at the Haridwar facility. The board has sanctioned ₹15 crore to add 800 MT of annual capacity to the existing 200 MT base, which is currently operating at 50% utilisation. The rationale is to cater to growing demand and serve customers requiring larger volumes. This expansion is targeted for completion between May 2026 and March 2027.

Parameter: Details
Existing Cosmetic Capacity (Annual): 200 MT
Existing Capacity Utilisation: 50%
Proposed Capacity Addition (Annual): 800 MT
Timeline: May 2026 – March 2027
Investment Required: ₹15 crore
Mode of Financing: Internal accruals – 25%, Term Loan – 75%

Investment Summary

The four board-approved projects collectively represent a total investment outlay of ₹132 crore, as summarised below:

Project: Location Investment
Spunlace Non-Woven New Line: Panoli ₹94 crore
Solar Power Project: Panoli ₹13 crore
Kitchen Roll & Medical Products: CPD Panoli ₹10 crore
Cosmetics Division Expansion: CPD Haridwar ₹15 crore
Total: ₹132 crore

All four projects are subject to requisite approvals and are to be financed through a uniform structure of 25% internal accruals and 75% term loans. The disclosures were made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Ginni Filaments

1 Day5 Days1 Month6 Months1 Year5 Years
-2.94%+6.30%+24.24%+4.94%+87.89%+63.69%

With 75% of the ₹132 crore expansion financed through term loans, how might the increased debt burden impact Ginni Filaments' credit ratings and interest coverage ratios in the near term?

Given that the cosmetics division is currently operating at only 50% utilisation, what demand signals or customer commitments justify a 5x capacity expansion at Haridwar?

How could Ginni Filaments' entry into medical products like gauzes, swabs, and bandages position it competitively against established players in the healthcare consumables segment?

More News on Ginni Filaments

1 Year Returns:+87.89%